Cover Story
2021 Progress Report: Part 1
Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. From remarkable new...
Features
Is It Time for a New Approach to Treating Cushing’s Syndrome?
David A. Katz, PhD, CSO of Sparrow Pharmaceuticals, launched the company to specifically target the therapies bigger companies were ignoring. He talks to Endocrine...
